Immediate Impact

8 by Nobel laureates 13 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

ADHD Pharmacotherapy and Mortality in Individuals With ADHD
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
2 intermediate papers

Works of S Malcolm being referenced

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial
2004
Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine
2000

Author Peers

Author Last Decade Papers Cites
S Malcolm 342 93 140 122 19 593
Ronald E. Saul 289 75 119 192 20 657
Lelland C. Tolbert 213 41 49 206 22 729
Klaus-Peter Kühl 254 88 74 198 17 635
Natalie Freeman 209 54 57 166 40 696
Verônica Contini 317 20 51 172 40 683
Maria Spanò 270 36 31 110 24 650
B. E. Jones 93 60 45 163 30 686
Sally I. Sharp 286 86 124 101 26 728
Robert H. Loiselle 224 32 35 50 30 646
Joar Guterstam 214 27 44 114 24 576

All Works

Loading papers...

Rankless by CCL
2026